Valuation Kobayashi Pharmaceutical Co., Ltd. Deutsche Boerse AG

Stocks

KOY

JP3301100008

Personal Products

Real-time Estimate 09:27:03 16/09/2026 BST 5-day change 1st Jan Change
32.50 EUR +2.85% Intraday chart for Kobayashi Pharmaceutical Co., Ltd. +1.29% +9.79%

Company Valuation: Kobayashi Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 704,427 650,295 503,841 463,131 403,511 432,205 - -
Change - -7.68% -22.52% -8.08% -12.87% 7.11% - -
Enterprise Value (EV) 1 596,011 546,554 424,992 398,232 333,575 369,792 362,181 356,409
Change - -8.3% -22.24% -6.3% -16.24% 10.86% -2.06% -1.59%
P/E 35.8x 34.8x 25.3x 46x 110x 41.8x 32.1x 26x
PBR 3.59x 3.47x 2.47x 2.18x 1.92x 2.06x 2x 1.93x
PEG - 12.08x 7.7x -0.9x -1.7x 0x 1.1x 1.1x
Capitalization / Revenue 4.54x 3.91x 2.9x 2.8x 2.43x 2.51x 2.41x 2.32x
EV / Revenue 3.84x 3.29x 2.45x 2.4x 2.01x 2.15x 2.02x 1.91x
EV / EBITDA 19.3x 17.1x 13.3x 12.1x 14.1x 16.8x 13.5x 11.5x
EV / EBIT 22.9x 20.5x 16.5x 16x 22.4x 28.9x 20.9x 16.7x
EV / FCF 31.8x 31.1x -350x -29.2x 68.5x 25.7x 23.8x 20.8x
FCF Yield 3.15% 3.22% -0.29% -3.42% 1.46% 3.89% 4.2% 4.8%
Dividend per Share 2 83 90 101 102 104 106 109.5 114.3
Rate of return 0.92% 1% 1.49% 1.64% 1.92% 1.82% 1.88% 1.97%
EPS 2 252.4 259.6 268.2 135.4 49.19 139.1 181.1 223.7
Distribution rate 32.9% 34.7% 37.7% 75.3% 211% 76.2% 60.5% 51.1%
Net sales 1 155,252 166,258 173,455 165,600 165,742 172,061 179,446 186,503
EBITDA 1 30,900 32,027 31,837 32,800 23,600 22,012 26,890 31,112
EBIT 1 26,065 26,669 25,780 24,860 14,923 12,780 17,350 21,293
Net income 1 19,715 20,022 20,338 10,067 3,656 10,438 13,554 16,348
Net Debt 1 -108,416 -103,741 -78,849 -64,899 -69,936 -62,413 -70,024 -75,796
Reference price 2 9,040.00 9,030.00 6,790.00 6,230.00 5,428.00 5,814.00 5,814.00 5,814.00
Nbr of stocks (in thousands) 77,923 72,015 74,203 74,339 74,339 74,339 - -
Announcement Date 04/02/22 14/02/23 09/02/24 10/02/25 10/02/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
21.55x4.11x15.05x3% 341B
18.33x2.72x12x3.52% 135B
23.66x3.55x14.93x2.44% 69.35B
40.28x6.47x28.06x2.32% 47.47B
32.46x2.56x14.22x1.66% 34.82B
18.88x2.66x11.1x4.71% 34.42B
22.24x1.62x10.36x2.27% 20.08B
19.64x1.24x8.15x1.34% 18.76B
15.29x1.47x8.47x3.48% 18.29B
Average 23.59x 2.94x 13.59x 2.75% 79.85B
Weighted average by Cap. 22.60x 3.60x 14.62x 2.96%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 4967 Stock
  4. KOY Stock
  5. Valuation Kobayashi Pharmaceutical Co., Ltd.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!